nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.04.2017 | Original Article

Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity

verfasst von: P. Di Bonito, L. Pacifico, C. Chiesa, G. Valerio, E. Miraglia del Giudice, C. Maffeis, A. Morandi, C. Invitti, M. R. Licenziati, S. Loche, G. Tornese, F. Franco, M. Manco, M. G. Baroni, for the “CARdiometabolic risk factors in overweight and obese children in ITALY” (CARITALY) Study Group

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate in a large sample of overweight/obese (OW/OB) children and adolescents the prevalence of prediabetic phenotypes such as impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), and to assess their association with cardiometabolic risk (CMR) factors including hepatic steatosis (HS).

Methods

Population data were obtained from the CARdiometabolic risk factors in children and adolescents in ITALY study. Between 2003 and 2013, 3088 youths (972 children and 2116 adolescents) received oral glucose tolerance test (OGTT) and were included in the study. In 798 individuals, abdominal ultrasound for identification of HS was available.

Results

The prevalence of IFG (3.2 vs. 3.3%) and IGT (4.6 vs. 5.0%) was similar between children and adolescents. Children with isolated IGT had a 2–11 fold increased risk of high LDL-C, non-HDL-C, Tg/HDL-C ratio, and low insulin sensitivity, when compared to those with normal glucose tolerance (NGT). No significant association of IFG with any CMR factor was found in children. Among adolescents, IGT subjects, and to a lesser extent those with IFG, showed a worse CMR profile compared to NGT subgroup. In the overall sample, IGT phenotype showed a twofold increased risk of HS compared to NGT subgroup.

Conclusions

Our study shows an unexpected similar prevalence of IFG and IGT between children and adolescents with overweight/obesity. The IGT phenotype was associated with a worse CMR profile in both children and adolescents. Phenotyping prediabetes conditions by OGTT should be done as part of prediction and prevention of cardiometabolic diseases in OW/OB youth since early childhood.

Nur mit Berechtigung zugänglich

Cunningham SA, Kramer MR, Narayan KM (2014) Incidence of childhood obesity in the United States. N Engl J Med 370(5):403–411CrossRefPubMedPubMedCentral

Shashaj B, Bedogni G, Graziani MP et al (2014) Origin of cardiovascular risk in overweight preschool children: a cohort study of cardiometabolic risk factors at the onset of obesity. JAMA Pediatr 168(10):917–924CrossRefPubMed

Giannini C, Caprio S (2013) Progression of β-cell dysfunction in obese youth. Curr Diab Rep 13(1):89–95CrossRefPubMed

Meyer C, Pimenta W, Woerle HJ et al (2006) Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29(8):1909–1914CrossRefPubMed

Nathan DM, Davidson MB, DeFronzo RA et al (2007) American Diabetes Association. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30(3):753–759CrossRefPubMed

American Diabetes Association (2016) Classification and diagnosis of diabetes. Diabetes Care 39(Suppl 1):S13–S22

Morrison KM, Xu L, Tarnopolsky M, Yusuf Z, Atkinson SA, Yusuf S (2012) Screening for dysglycemia in overweight youth presenting for weight management. Diabetes Care 35(4):711–716CrossRefPubMedPubMedCentral

Hagman E, Reinehr T, Kowalski J, Ekbom A, Marcus C, Holl RW (2014) Impaired fasting glucose prevalence in two nationwide cohorts of obese children and adolescents. Int J Obes 38(1):40–45CrossRef

Vukovic R, Mitrovic K, Milenkovic T, Todorovic S, Zdravkovic D (2012) Type 2 diabetes mellitus and impaired glucose regulation in overweight and obese children and adolescents living in Serbia. Int J Obes 36(11):1479–1481CrossRef

10.

Ek AE, Rössner SM, Hagman E, Marcus C (2015) High prevalence of prediabetes in a Swedish cohort of severely obese children. Pediatr Diabetes 16(2):117–128CrossRefPubMed

11.

Hagman E, Arani PI, Fischer M et al (2014) Blood sugar levels are higher in obese young children in Sweden than in Poland. Acta Paediatr 103(11):1174–1178CrossRefPubMed

12.

Sinha R, Fisch G, Teague B et al (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346(11):802–810CrossRefPubMed

13.

Tester J, Sharma S, Jasik CB, Mietus-Snyder M, Tinajero-Deck L (2013) Gender differences in prediabetes and insulin resistance among 1356 obese children in Northern California. Diabetes Metab Syndr 7(3):161–165CrossRefPubMed

14.

Shalitin S, Abrahami M, Lilos P, Phillip M (2005) Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. Int J Obes 29(6):571–578CrossRef

15.

Brufani C, Ciampalini P, Grossi A et al (2010) Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy. Pediatr Diabetes 11(1):47–54CrossRefPubMed

16.

Brufani C, Fintini D, Ciampalini P et al (2011) Pre-diabetes in Italian obese children and youngsters. J Endocrinol Invest 34(9):e275–e280PubMed

17.

Invitti C, Guzzaloni G, Gilardini L, Morabito F, Viberti G (2003) Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care 26(1):118–124CrossRefPubMed

18.

Grandone A, Amato A, Luongo C, Santoro N, Perrone L, Miraglia Del Giudice E (2008) High-normal fasting glucose levels are associated with increased prevalence of impaired glucose tolerance in obese children. J Endocrinol Invest 31(12):1098–1102CrossRefPubMed

19.

Cali AM, De Oliveira AM, Kim H et al (2009) Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology 49(6):1896–1903CrossRefPubMedPubMedCentral

20.

D’Adamo E, Cali AM, Weiss R et al (2010) Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 33(8):1817–1822CrossRefPubMedPubMedCentral

21.

Di Bonito P, Valerio G, Grugni G et al (2015) Comparison of non-HDL-cholesterol versus triglycerides-to-HDL-cholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight/obese children: the CARITALY study. Nutr Metab Cardiovasc Dis 25(5):489–494CrossRefPubMed

22.

Canadian Paediatric Society (2003) Age limits and adolescents. Paediatr Child Health 8(9):577CrossRef

23.

Cole TJ, Lobstein T (2012) Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes 7(4):284–294CrossRefPubMed

24.

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute (2011) Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128(Suppl. 5):S213–S256CrossRefPubMedCentral

25.

Shashaj B, Luciano R, Contoli B et al (2016) Reference ranges of HOMA-IR in normal-weight and obese young Caucasians. Acta Diabetol 53(2):251–260CrossRefPubMed

26.

Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S (2005) Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 28(4):902–909CrossRefPubMed

27.

Körner A, Wiegand S, Hungele A et al (2013) Longitudinal multicenter analysis on the course of glucose metabolism in obese children. Int J Obes 37(7):931–936CrossRef

28.

Kleber M, Lass N, Papcke S, Wabitsch M, Reinehr T (2010) One-year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: high conversion rate to normal glucose tolerance. Diabet Med 27(5):516–521CrossRefPubMed

29.

Kleber M, deSousa G, Papcke S, Wabitsch M, Reinehr T (2011) Impaired glucose tolerance in obese white children and adolescents: three to five year follow-up in untreated patients. Exp Clin Endocrinol Diabetes 119(3):172–176CrossRefPubMed

30.

Festa A, D’Agostino R Jr, Hanley AJ, Karter AJ, Saad MF, Haffner SM (2004) Differences in insulin resistance in nondiabetic individuals with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 53(6):1549–1555CrossRefPubMed

31.

Lorenzo C, Hartnett S, Hanley AJ et al (2013) Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study. J Clin Endocrinol Metab 98(4):1622–1630CrossRefPubMedPubMedCentral

32.

Di Bonito P, Licenziati MR, Baroni MG et al (2014) High normal post-load plasma glucose, cardiometabolic risk factors and signs of organ damage in obese children. Obesity (Silver Spring) 22(8):1860–1864CrossRef

33.

Weiss R, Otvos JD, Sinnreich R, Miserez AR, Kark JD (2011) The triglyceride to high-density lipoprotein-cholesterol ratio in adolescence and subsequent weight gain predict nuclear magnetic resonance-measured lipoprotein subclasses in adulthood. J Pediatr 158(1):44–50CrossRefPubMed

34.

Li WD, Fu KF, Li GM et al (2015) Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus. World J Gastroenterol 21(32):9607–9613CrossRefPubMedPubMedCentral

35.

Pisto P, Santaniemi M, Bloigu R, Ukkola O, Kesäniemi Y (2014) Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. BMJ Open 4(3):e004973CrossRefPubMedPubMedCentral

36.

Bonora E, Targher G, Alberiche M et al (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23(1):57–63CrossRefPubMed

Titel: Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity
verfasst von: P. Di Bonito
L. Pacifico
C. Chiesa
G. Valerio
E. Miraglia del Giudice
C. Maffeis
A. Morandi
C. Invitti
M. R. Licenziati
S. Loche
G. Tornese
F. Franco
M. Manco
M. G. Baroni
for the “CARdiometabolic risk factors in overweight and obese children in ITALY” (CARITALY) Study Group
Publikationsdatum: 01.04.2017
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 4/2017
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-016-0576-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity

Abstract

Objective

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Objective

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2017

Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome

Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications

Low regulatory T cell and high IL-17 mRNA expression in a mouse Graves’ disease model

Thiol/disulfide homeostasis in postmenopausal osteoporosis

“The Penitent Magdalene”: Jusepe de Ribera (1591–1652)

Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin